Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02222688
Brief Title: UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia

First Submitted : August 19, 2014
First Submitted that Met QC Criteria : August 20, 2014
First Posted : August 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 25, 2019
Last Update Posted : March 27, 2019